GENEVA, Aug. 21 -- BEIJING TIDE PHARMACEUTICAL CO., LTD. filed a patent application (CN2026/078592) for “ATR KINASE INHIBITOR IN COMBINATION WITH ANTI-PD-1 ANTIBODY AND/OR ANTI-PD-L1 ANTIBODY TO TREAT CANCER”. With publication no. WO/2026/171173, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/5377

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....